Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents our disaggregated revenue for the periods presented (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
JAKAFI revenues, net	$	741,181	$	636,252	$	2,018,993	$	1,898,605
OPZELURA revenues, net	139,272		91,836		346,691		228,621
ICLUSIG revenues, net	29,745		27,721		86,950		84,493
PEMAZYRE revenues, net	20,661		18,942		58,606		62,989
MINJUVI/MONJUVI revenues, net	31,439		8,348		86,429		28,063
ZYNYZ revenues, net	694		98		1,812		668
Total product revenues, net	962,992		783,197		2,599,481		2,303,439
JAKAVI product royalty revenues	115,741		96,551		304,653		263,691
OLUMIANT product royalty revenues	34,796		29,615		97,087		95,779
TABRECTA product royalty revenues	5,928		4,139		16,460		13,115
PEMAZYRE product royalty revenues	414		523		1,838		1,284
Total product royalty revenues	156,879		130,828		420,038		373,869
Milestone and contract revenues	18,000		5,000		43,000		5,000
Total revenues	$	1,137,871	$	919,025	$	3,062,519	$	2,682,308